ING Groep NV Has $801,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• ING Groep NV has significantly decreased its stake in Henry Schein, Inc., reducing holdings by 99.0% to 11,689 shares, valued at $801,000.
• Multiple research firms have lowered their price targets for Henry Schein, with Wells Fargo setting a new target of $75.00 and Barrington Research lowering theirs to $78.00.
• Henry Schein reported earnings of $1.10 per share, missing estimates by ($0.09), despite a revenue increase of 3.3% year-over-year.

ING Groep NV reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 99.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,689 shares of the company's stock after selling 1,151,398 shares during the quarter. ING Groep NV's holdings in Henry Schein were worth $801,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Investment Management Corp VA ADV bought a new position in Henry Schein in the 4th quarter valued at about $32,000. Rakuten Securities Inc. bought a new position in Henry Schein in the 1st quarter valued at about $34,000. Whittier Trust Co. raised its holdings in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after acquiring an additional 700 shares during the period. UMB Bank n.a. increased its holdings in shares of Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Finally, Allworth Financial LP increased its holdings in shares of Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares during the period. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HSIC. Wells Fargo & Company dropped their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Barrington Research dropped their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday. Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price target (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. JPMorgan Chase & Co. dropped their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, Stifel Nicolaus reissued a "hold" rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $75.58.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $0.04 during midday trading on Friday, reaching $65.94. 1,931,964 shares of the company were exchanged, compared to its average volume of 2,156,766. The stock's 50-day moving average price is $71.07 and its 200-day moving average price is $71.12. The stock has a market cap of $8.00 billion, a P/E ratio of 21.27, a PEG ratio of 2.17 and a beta of 0.81. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a quick ratio of 0.75, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The business's quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.23 EPS. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.